Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Enamine, MRC LMB, IOCB announce alliance
July 2012
SHARING OPTIONS:

KIEV, UkraineóEnamine Ltd., the Medical Research Council Laboratory of Molecular Biology (MRC LMB) of Cambridge, United Kingdom, and the Institute of Organic Chemistry and Biochemistry of the Academy of Sciences of the Czech Republic (IOCB) in Prague have signed a collaboration agreement aimed at identifying novel rhomboid protease inhibitors that could treat immune, oncological, infectious, parasitic and cardiovascular diseases. Per the agreement, Enamine will grant the MRC LMB and IOCB access to its drug discovery capabilities, and the three partners will jointly own any resulting intellectual property and seek pharmaceutical partners for the clinical development of any small molecule inhibitors produced. MRC Technology negotiated the agreement on behalf of MRC LMB. No financial details were disclosed.

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.